Australia markets open in 8 hours 45 minutes

Cutia Therapeutics (2487.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
7.600-0.100 (-1.30%)
At close: 04:08PM HKT
Currency in HKD

Valuation measures4

Market cap (intra-day) 2.34B
Enterprise value 1.21B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)10.42
Price/book (mrq)1.58
Enterprise value/revenue 8.01
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-64.92%
S&P500 52-week change 328.04%
52-week high 332.600
52-week low 35.570
50-day moving average 37.371
200-day moving average 314.059

Share statistics

Avg vol (3-month) 3774.87k
Avg vol (10-day) 3497.42k
Shares outstanding 5304.02M
Implied shares outstanding 6304.02M
Float 817.7M
% held by insiders 14.13%
% held by institutions 190.31%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-314.49%

Management effectiveness

Return on assets (ttm)-21.39%
Return on equity (ttm)-3,823.41%

Income statement

Revenue (ttm)137.62M
Revenue per share (ttm)0.67
Quarterly revenue growth (yoy)864.50%
Gross profit (ttm)N/A
EBITDA -508.8M
Net income avi to common (ttm)-1.96B
Diluted EPS (ttm)-10.550
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.27B
Total cash per share (mrq)4.19
Total debt (mrq)243.76M
Total debt/equity (mrq)18.07%
Current ratio (mrq)5.56
Book value per share (mrq)4.44

Cash flow statement

Operating cash flow (ttm)-381.31M
Levered free cash flow (ttm)-250.48M